Live symbol workspace

MRNA market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Status Chart ready

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for MRNA skewed bullish (3 of 6 scored calls).

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

34%

▲ 0.8 pts vs previous week

Avg confidence across 18 calls in the last 7 days

What sources say

Bullish 3 articles

Merck, Moderna Stocks Soar After Melanoma Trial Success

Merck, Moderna Melanoma Vaccine Study Succeeds

RocketLab Rises on Space Interest; Moderna Moves on Flu Shot | Stock Movers

Neutral 3 articles

Moderna’s stock doubles on promising cancer-vaccine results

Moderna Just Got FDA Clearance for Flu Vaccine. The Stock Slips.

US Stock Futures Flat After S&P500, Dow End At Record Highs On Strong Earnings, Easing Geopolitical Concerns — PLTR, AZN, CMG, MRNA In Focus

MRNA News Intelligence (13 articles)

AI-curated news influencing MRNA price, sentiment, and trend

Explore All MRNA News with AI Analysis

Economy

1 hour, 13 minutes ago

Moderna Surges on Cancer Vaccine; Estee Lauder Rallies on Earnings | Stock Movers

On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock’s biggest …

Impact on MRNA: Potentially positive price action expected

Analysis of stock market developments showing bullish sentiment. High (70%)

View full analysis →

Bloomberg 70% confidence

Economy

2 hours, 31 minutes ago

Merck, Moderna Stocks Soar After Melanoma Trial Success

Shares of Moderna and Merck soared on Wednesday morning after a study showed that a vaccine they produced had promising …

Impact on MRNA: Potentially positive price action expected

Analysis of stock market developments showing bullish sentiment. Medium (60%)

View full analysis →

Bloomberg 60% confidence

Economy

3 hours, 17 minutes ago

Merck, Moderna Melanoma Vaccine Study Succeeds

Merck and Moderna announced positive results from a large late-stage trial of their personalized mRNA cancer vaccine, which significantly reduced …

Impact on MRNA: Potentially positive price action expected

Financial market analysis indicating bullish sentiment based on current trends. Medium (60%)

View full analysis →

Bloomberg 60% confidence

Stocks

4 hours, 43 minutes ago

Moderna’s stock doubles on promising cancer-vaccine results

The vaccine candidate pairs an mRNA therapy with the cancer drug Keytruda.

Impact on MRNA: Neutral market sentiment indicated

Analysis of stock market developments showing neutral sentiment. Medium (50%)

View full analysis →

MarketWatch 50% confidence

Economy

1 week, 2 days ago

RocketLab Rises on Space Interest; Moderna Moves on Flu Shot | Stock Movers

On this episode of Stock Movers: - RocketLab (RKLB) shares are higher this morning after rising Friday, following earnings from …

Impact on MRNA: Potentially positive price action expected

Analysis of stock market developments showing bullish sentiment. Medium (60%)

View full analysis →

Bloomberg 60% confidence

Economy

1 week, 6 days ago

Moderna Just Got FDA Clearance for Flu Vaccine. The Stock Slips.

Moderna’s mRNA-based flu vaccine, mFlusiva, is approved by the Food and Drug Administration for adults aged 50 and over.

Impact on MRNA: Neutral market sentiment indicated

Analysis of stock market developments showing neutral sentiment. Medium (50%)

View full analysis →

Yahoo Finance 50% confidence